Real-world Effectiveness and Safety Study of Sacituzumab Govitecan in Chinese Metastatic Breast Cancer

NCT06356519 · clinicaltrials.gov ↗

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Sacituzumab Govitecan

Sponsor

Fudan University